U.S. flag

An official website of the United States government

NM_000180.4(GUCY2D):c.935C>T (p.Thr312Met) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003764783.3

Allele description [Variation Report for NM_000180.4(GUCY2D):c.935C>T (p.Thr312Met)]

NM_000180.4(GUCY2D):c.935C>T (p.Thr312Met)

Gene:
GUCY2D:guanylate cyclase 2D, retinal [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000180.4(GUCY2D):c.935C>T (p.Thr312Met)
Other names:
NM_000180.4(GUCY2D):c.935C>T
HGVS:
  • NC_000017.11:g.8004065C>T
  • NG_009092.1:g.6396C>T
  • NM_000180.4:c.935C>TMANE SELECT
  • NP_000171.1:p.Thr312Met
  • NP_000171.1:p.Thr312Met
  • NC_000017.10:g.7907383C>T
  • NM_000180.3:c.935C>T
  • Q02846:p.Thr312Met
Protein change:
T312M
Links:
UniProtKB: Q02846#VAR_067171; dbSNP: rs61749673
NCBI 1000 Genomes Browser:
rs61749673
Molecular consequence:
  • NM_000180.4:c.935C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cone-rod dystrophy 6 (CORD6)
Synonyms:
RETINAL CONE DYSTROPHY 2; Cone dystrophy progressive
Identifiers:
MONDO: MONDO:0011143; MedGen: C1866293; Orphanet: 1872; OMIM: 601777
Name:
Leber congenital amaurosis 1 (LCA1)
Synonyms:
AMAUROSIS CONGENITA OF LEBER I; RETINAL BLINDNESS, CONGENITAL; Congenital absence of the rods and cones; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008764; MedGen: C2931258; Orphanet: 65; OMIM: 204000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004593105Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 12, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical phenotypes in carriers of Leber congenital amaurosis mutations.

Galvin JA, Fishman GA, Stone EM, Koenekoop RK.

Ophthalmology. 2005 Feb;112(2):349-56.

PubMed [citation]
PMID:
15691574

Evaluation of genotype-phenotype associations in leber congenital amaurosis.

Galvin JA, Fishman GA, Stone EM, Koenekoop RK.

Retina. 2005 Oct-Nov;25(7):919-29.

PubMed [citation]
PMID:
16205573
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004593105.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 312 of the GUCY2D protein (p.Thr312Met). This variant is present in population databases (rs61749673, gnomAD 0.03%). This missense change has been observed in individuals with autosomal recessive GUCY2D-related conditions (PMID: 15691574, 16205573, 19959640, 31964843, 34048777). ClinVar contains an entry for this variant (Variation ID: 98610). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GUCY2D protein function. This variant disrupts the p.Thr312 amino acid residue in GUCY2D. Other variant(s) that disrupt this residue have been observed in individuals with GUCY2D-related conditions (PMID: 26047050), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2025